These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22679119)

  • 1. Systemic therapy for advanced pancreatic neuroendocrine tumors: an update.
    Reidy-Lagunes DL
    J Natl Compr Canc Netw; 2012 Jun; 10(6):777-83. PubMed ID: 22679119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Management of Pancreatic Neuroendocrine Tumors: Current and Future Therapy.
    Chan JA; Kulke MH
    Surg Oncol Clin N Am; 2016 Apr; 25(2):423-37. PubMed ID: 27013373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors.
    Cives M; Pelle' E; Quaresmini D; Mandriani B; Tucci M; Silvestris F
    Curr Treat Options Oncol; 2019 Jul; 20(9):72. PubMed ID: 31346813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic therapy for advanced pancreatic neuroendocrine tumors.
    Kulke MH
    Semin Oncol; 2013 Feb; 40(1):75-83. PubMed ID: 23391115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.
    Krug S; Gress TM; Michl P; Rinke A
    Digestion; 2017; 96(2):67-75. PubMed ID: 28728148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors.
    Raj N; Reidy-Lagunes D
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):119-33. PubMed ID: 26614372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic neuroendocrine and carcinoid tumors: what's new, what's old, and what's different?
    Reidy-Lagunes D; Thornton R
    Curr Oncol Rep; 2012 Jun; 14(3):249-56. PubMed ID: 22434313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Updates in the Management of Advanced Pancreatic Neuroendocrine Tumors.
    Cho CM
    Korean J Gastroenterol; 2019 Mar; 73(3):124-131. PubMed ID: 31013555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel fluoropyrimidine-based chemotherapy for advanced well-differentiated neuroendocrine tumors: a clinical update.
    Zhang H; Shen G; Zhang S; Du F; Cao Y; Jiang J; Zheng F; Ma X; Wang Z; Ren D; Ahmad R; Zhao F; Zhao J
    Expert Opin Pharmacother; 2018 Jun; 19(8):795-807. PubMed ID: 29693454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy for GI and pancreatic NETs].
    Doi T
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):838-42. PubMed ID: 23863723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract.
    Cives M; Strosberg J
    Curr Treat Options Oncol; 2017 Mar; 18(3):14. PubMed ID: 28286921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the mTOR signaling pathway in neuroendocrine tumors.
    Chan J; Kulke M
    Curr Treat Options Oncol; 2014 Sep; 15(3):365-79. PubMed ID: 25092520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the management of unresectable or metastatic pancreatic neuroendocrine tumors: chemotherapy, targeted therapy, hormonal treatment, and future directions.
    Bilici A
    Asian Pac J Cancer Prev; 2015; 16(6):2151-9. PubMed ID: 25824731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy.
    Leung R; Lang B; Wong H; Chiu J; Yat WK; Shek T; Cho WY; Yau LC; Yau T
    Anticancer Agents Med Chem; 2013 Mar; 13(3):382-8. PubMed ID: 23092266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis.
    Mujica-Mota R; Varley-Campbell J; Tikhonova I; Cooper C; Griffin E; Haasova M; Peters J; Lucherini S; Talens-Bou J; Long L; Sherriff D; Napier M; Ramage J; Hoyle M
    Health Technol Assess; 2018 Sep; 22(49):1-326. PubMed ID: 30209002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of sunitinib in patients with advanced neuroendocrine tumors.
    Kulke MH; Lenz HJ; Meropol NJ; Posey J; Ryan DP; Picus J; Bergsland E; Stuart K; Tye L; Huang X; Li JZ; Baum CM; Fuchs CS
    J Clin Oncol; 2008 Jul; 26(20):3403-10. PubMed ID: 18612155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic neuroendocrine tumors: does chemotherapy work?
    Tejani MA; Saif MW
    JOP; 2014 Mar; 15(2):132-4. PubMed ID: 24618436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Chemotherapy in Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors.
    Strosberg J; Goldman J; Costa F; Pavel M
    Front Horm Res; 2015; 44():239-47. PubMed ID: 26303716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy in the treatment of neuroendocrine malignant tumors.
    Rougier P; Mitry E
    Digestion; 2000; 62 Suppl 1():73-8. PubMed ID: 10940691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the systemic treatment of pancreatic neuroendocrine tumors.
    Yalcin S
    Cancer Treat Rev; 2011 Apr; 37(2):127-32. PubMed ID: 20705397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.